https://www.selleckchem.com/pr....oducts/NVP-AUY922.ht
These levels were negatively correlated with several clinical symptomatic scores of MDD, but not those of SCZ. In addition, the levels of LPA 226 were significantly correlated with the levels of LPC 226 among all of three groups. On the other hand, the levels of LPA 226 were not correlated with ATX activity in patients with MDD and SCZ. The lower levels of LPA 226 in patients with MDD and SCZ suggests an abnormality of LPA 226 metabolism. In addition, several depressive symptoms in patients with MDD were significantly associated with